Viva Biotech Holdings's total assets for Q2 2025 were ¥6.88B, a decrease of -2.38% from the previous quarter. HK:1873 total liabilities were ¥2.98B for the fiscal quarter, a -8.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.